FIELD: medicine.
SUBSTANCE: invention relates to medicine. Disclosed is a therapeutic dosage form for pain management, which contains 6'-fluoro-(N-methyl- or N,N-dimethyl)-4-phenyl-4',9'-dihydro-3'N-spiro[cyclohexane-1,1'-pirano [3,4,b]indole]-4-amine or its physiologically acceptable salt and self-emulsifying preparation containing surfactant having hydrophilic-lipophilic balance (HLB) at least of 10 and oil, wherein oil is selected from group comprising saturated C8-C14 fatty acids, unsaturated C8-C18 fatty acids and their esters, mixture of saturated and unsaturated C8-C14 fatty acids, triglycerides of fatty acids, esters of propylene glycol and fatty acid. Drug dosage form is intended for introduction of twice a day, once a day or less frequently.
EFFECT: technical result consists in the immediate release 6'-fluoro-(N-methyl- or N,N-dimethyl)-4-phenyl-4',9'-dihydro-3'N-spiro[cyclohexane-1,1'-pirano[3,4,b]indole]-4-amine of the dosage form, in good bioavailability, despite low solubility in water and providing a long period of semi-elimination from body.
13 cl, 1 dwg, 28 tbl
Title |
Year |
Author |
Number |
DOSED DRUG FORM CONTAINING 6-FLUORO-(N-METHYL- OR N,N-DIMETHYL-)-4-PHENYL-4', 9'-DIHYDRO-3'N-SPIRO[CYCLOHEXANE-1,1'-PYRANO[3,4,INDOLE]-4-AMINE FOR NOCICEPTIVE PAIN TREATMENT |
2011 |
- Gryuning Nadya
- Shiller Mark
- Fridrikh Ingo
- Kerbi Kris
- Khemani Ashish
- Botmer Jokhn
- Sholts Andreas
|
RU2631481C2 |
DRUG DOSAGE FORM CONTAINING 6'-FLUORO-(N-METHYL- OR N, N-DIMETHYL-)-4-PHENYL-4', 9'-DIHYDRO-3'H-SPIRO[CYCLOHEXANE-1, 1'-PYRANO[3, 4, b]INDOLE]-4-AMINE |
2011 |
- Shiller Mark
- Gryuning Nadya
- Khemani Ashish
|
RU2589831C2 |
MEDICINAL DOSAGE FORM, WHICH CONTAINS 6'-FLUOR-(N-METHYL-OR N,N-DIMETHYL)-4-PHENYL-4,9'-DIHYDRO-3'N-SPIRO[CYCLOHEXANE-1,1'-PYRANO[3,4, B]INDOLE]-4-AMINE FOR NEUROPATHIC PAIN TREATMENT |
2011 |
- Gryuning Nadya
- Shiller Mark
- Fridrikh Ingo
- Kerbi Kris
- Khemani Ashish
- Botmer Jokhn
- Sholts Andreas
|
RU2638818C2 |
MEDICINAL DOSAGE FORM, WHICH CONTAINS 6'-FLUOR-(N-METHYL-OR N,N-DIMETHYL)-4-PHENYL-4',9'-DIHYDRO-3'H-SPIRO[CYCLOHEXANE-1,1'-PYRANO[3,4,b]INDOLE]-4-AMINE |
2011 |
- Shiller Mark
- Grjuning Nadja
- Fridrikh Ingo
- Kerbi Kris
|
RU2582390C2 |
SEMIFIRM SYSTEMS CONTAINING DERIVATIVES OF AZETIDINUM |
2004 |
- Perakkija Marija-Tereza
- Kote Sofi
- Bobino Valeri
|
RU2343915C2 |
ANTAGONISTS NEUROKININ-1 COMPOSITIONS FOR INTRAVENOUS INTRODUCTION |
2010 |
- Van Dzhiansheng
- Gupta Pranav
- Montejt Devid
- Bkhattachariya Soumendu
|
RU2642234C2 |
SALTS OF 1-(4-(2-((1-(3,4-DIFLUOROPHENYL)-1N-PYRAZOL-3-YL)METHOXY)ETHYL)PIPERAZIN-1-YL)ETHANONE |
2016 |
- Torrens-Jover Antoni
- Almansa Rosales Carmen
|
RU2727974C2 |
TOSYLATE SALT OF TRANS-N-ISOBUTYL-3-FLUORO-3-[3-FLUORO-4-(PYRROLIDIN-1-YLMETHYL)PHENYL]CYCLOBUTANE CARBOXAMIDE |
2008 |
- Vager Trevis T.
- Batler Todd Uill'Jam
|
RU2451016C2 |
[4-(5-AMINOMETHYL-2-FLOUROPHENYL)-PYPERIDIN-1-YL]-(4-BROMINE-3-PROPOXYTHIOPHENE-2-YL)-METHALON HYDROCHLORIDE AS INHIBITOR OF MAST CELLS TRYPTASE |
2005 |
- Gao Chzhunli
- Dehvis Larri
- Levell Dzhulian
- Chekaj Mark
- Sledeski Adam V.
- Addad Ehl'-Bdaui
|
RU2330034C1 |
SELF-EMULSIFYING COMPOSITION FOR SCARCELY WATER-SOLUBLE MEDICAMENT |
1999 |
|
RU2257917C2 |